BCVA
Showing 1 - 25 of 1,561
Visual Impairment, Myopia, Hyperopia Trial in Newark (With Try-on glasses)
Completed
- Visual Impairment
- +3 more
- With Try-on glasses
-
Newark, CaliforniaEyeQue
Jan 20, 2023
Refractive Errors, Vision Disorders Trial in Newark (EQ103)
Recruiting
- Refractive Errors
- Vision Disorders
- EQ103
-
Newark, CaliforniaEyeQue
Jan 5, 2022
Imaging of the Angiofibrotic Switch in Neovascular AMD
Unknown status
- Age-related Macular Degeneration
- Choroidal Neovascularization
- Best-corrected Visual acuity testing (BCVA)
- +7 more
-
Vienna, AustriaMedical University of Vienna
Feb 19, 2020
Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial
Completed
- Diabetic Macular Edema
-
Seoul, Korea, Republic ofNovartis Investigative Site
Apr 4, 2023
Neovascular Age-related Macular Degeneration Trial in Worldwide (SOK583A1 (40 mg/mL), Eylea EU (40 mg/mL))
Active, not recruiting
- Neovascular Age-related Macular Degeneration
- SOK583A1 (40 mg/mL)
- Eylea EU (40 mg/mL)
-
Phoenix, Arizona
- +101 more
Jan 23, 2023
Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab
Recruiting
- Neovascular Age-related Macular Degeneration
- SUSVIMO (ranibizumab injection)
- LUCENTIS (ranibizumab injection)
-
Mesa, Arizona
- +32 more
Jan 13, 2023
Two Solutions of Intracameral Anesthesia During Cataract Surgery
Completed
- Cataract
- +2 more
- lignocaine
- +6 more
-
Lublin, PolandGeneral Department of Ophthalmology in Lublin
Nov 14, 2019
Recurrent Postoperative Macular Edema Treated With OZURDEX
Completed
- Macular Edema
-
Beijing, Beijing, ChinaPeking University Third Hosipital
May 10, 2022
Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML
Withdrawn
- Wet Macular Degeneration
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Prague, CzechiaDepartment of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022
Polypoidal Choroidal Vasculopathy Trial in Peking (non-interventional)
Recruiting
- Polypoidal Choroidal Vasculopathy
- non-interventional
-
Peking, Beijing, ChinaPeking Union Medical College Hospital
Nov 28, 2022
Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)
Completed
- Retinitis Pigmentosa
- Stem Cell Transplant
- Stem cell implantation
-
Istanbul, TurkeyAcıbadem University
Jan 25, 2023
Myopia Trial in Shenyang (0.01% atropine, 0.9% sodium chloride)
Not yet recruiting
- Myopia
- 0.01% atropine
- 0.9% sodium chloride
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Sep 10, 2023
Learn More About How Well Aflibercept 8 mg Works in Treating
Not yet recruiting
- Visual Impairment
- +2 more
- Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Australia
- +5 more
Oct 4, 2023
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)
Completed
- Proliferative Diabetic Retinopathy
- preoperative group and intraoperative group
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Jun 1, 2022
Myopia Trial (Atropine Sulfate)
Not yet recruiting
- Myopia
- Atropine Sulfate
- (no location specified)
Jul 20, 2022
Cornea Ulcer Trial in Cairo (Autologous platelet-rich plasma (PRP) eye drops)
Completed
- Cornea Ulcer
- Autologous platelet-rich plasma (PRP) eye drops
-
Cairo, EgyptAl-Azhar University
Aug 23, 2022
Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- Aflibercept(BAY86-5321, Eylea)
- (no location specified)
Jul 22, 2022
Early Real-world Evidence of Brolucizumab in Neovascular
Completed
- Neurovascular Age-related Macular Degeneration
-
Bangalore, India
- +3 more
Apr 26, 2023
Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)
Recruiting
- Macular Degeneration
- Autologous iPSC-derived RPE
-
Beijing, Beijing, ChinaBeijing Tongren Hospitol,Capital Medical University
Jun 30, 2022
Diabetic Macular Edema Trial (RC-28E, Aflibercept)
Not yet recruiting
- Diabetic Macular Edema
- RC-28E
- Aflibercept
- (no location specified)
May 30, 2023
Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab
Completed
- Diabetic Macular Edema
- Bevacizumab Injection [Avastin] (IVB-I)
- +2 more
- (no location specified)
May 24, 2022
Myopia Trial in Damietta (Implantable Collamer Lens (ICL), Implantable Intraocular Lens (IPCL))
Completed
- Myopia
- Implantable Collamer Lens (ICL)
- Implantable Intraocular Lens (IPCL)
-
Damietta, EgyptAkram Fekry Elgazzar
Sep 22, 2023
Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)
Completed
- Diabetic Macular Edema
- Lucentis alone group
- Lucentis dexamethasone group
-
Giza, Cairo, EgyptKhaled G Abueleinen
Feb 27, 2022